1. Home
  2. EVO vs NX Comparison

EVO vs NX Comparison

Compare EVO & NX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.07

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Quanex Building Products Corporation

NX

Quanex Building Products Corporation

HOLD

Current Price

$18.58

Market Cap

852.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVO
NX
Founded
1993
1927
Country
Germany
United States
Employees
4553
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
852.1M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
EVO
NX
Price
$3.07
$18.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$7.00
$28.00
AVG Volume (30 Days)
47.1K
286.5K
Earning Date
04-08-2026
06-04-2026
Dividend Yield
N/A
1.64%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,837,641,000.00
Revenue This Year
$1.37
$4.26
Revenue Next Year
$10.05
$1.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
43.81
52 Week Low
$2.31
$11.04
52 Week High
$4.42
$22.90

Technical Indicators

Market Signals
Indicator
EVO
NX
Relative Strength Index (RSI) 56.03 49.34
Support Level $2.88 $18.30
Resistance Level $3.75 $20.24
Average True Range (ATR) 0.07 0.74
MACD 0.01 0.06
Stochastic Oscillator 89.58 61.78

Price Performance

Historical Comparison
EVO
NX

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

About NX Quanex Building Products Corporation

Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: